wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36104098-DDE2EFE2-C039-4722-94C6-33421402E943
Q36104098-DDE2EFE2-C039-4722-94C6-33421402E943
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36104098-DDE2EFE2-C039-4722-94C6-33421402E943
Ponatinib as first-line treatment for patients with chronic myeloid leukaemia in chronic phase: a phase 2 study.
P2860
Q36104098-DDE2EFE2-C039-4722-94C6-33421402E943
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36104098-DDE2EFE2-C039-4722-94C6-33421402E943
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f212634fad7e7a46a331f77e42632b331b58d5a9
P2860
Ponatinib inhibits polyclonal drug-resistant KIT oncoproteins and shows therapeutic potential in heavily pretreated gastrointestinal stromal tumor (GIST) patients.